about
Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmationNon-immune thrombocytopenia responsive to antiretroviral therapy and HIV-2 infection.The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progressionDiagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection.Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.Artificial 64-Residue HIV-1 Enhancer-Binding Peptide Is a Potent Inhibitor of Viral Replication in HIV-1-Infected CellsImpact of naturally occurring amino acid variations on the detection of HIV-1 p24 in diagnostic antigen tests.Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNAConcurrent infections with vector-borne pathogens associated with fatal hemolytic anemia in a cattle herd in Switzerland.Prevalence of human T-cell leukemia virus types I and II in Switzerland.Immunophilins and HIV-1 infection.Lack of evidence for PERV expression after apoptosis-mediated horizontal gene transfer between porcine and human cells.Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant.[A possible new prognostic criterium for acute myelocytic leukemia: speed of the titer increase of antiviral antibodies after virus oncolysate injections]Ultra-sensitive and specific detection of porcine endogenous retrovirus (PERV) using a sequence-capture real-time PCR approach.Induction/activation and detection of occult viral agents present in mammalian cells.Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication.Quantification of in vitro retroviral replication using a one-tube real-time RT-PCR system incorporating direct RNA preparation.Resolution of plasma sample mix-ups through comparison of patient antibody patterns to E. coli.Frequent detection of HIV- and IgG-specific IgM and IgA antibodies in HIV-positive cord-blood sera: fine analysis by western blot.Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.Sensitive and quantitative detection of PCR-amplified HIV-1 DNA products by an enzyme linked immunoassay following solution hybridization with two differently labelled oligonucleotide probes.Xenotransplantation and viruses--the model of retroviruses.[HIV serodiagnosis in practice][Retroviruses, human tumors and autoimmune diseases]First documented case of human immunodeficiency virus type 2 infection in an asymptomatic Swiss subject.IgG, IgM, and IgA response to HIV in infants born to HIV-1 infected mothers. Swiss Neonatal HIV Study Group.[Human immunodeficiency virus: virological aspects]p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa.Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing.Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania.High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland.PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy.A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients.Quantification of HIV-1 p24 by a highly improved ELISA: an alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire.Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.Phylogenetic analysis and reclassification of caprine and ovine lentiviruses based on 104 new isolates: evidence for regular sheep-to-goat transmission and worldwide propagation through livestock trade.Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group.False-positive HIV-1 virus cultures using whole blood.Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART.
P50
Q33308261-DED03D87-95B8-4339-8093-8FAEFFFAA4DEQ33371345-8411BF24-FB9C-4D4E-A2E5-E1E6CFD4A5D3Q33785345-32181AC1-6BDD-42C5-8397-638230D28078Q34231138-CBBCD0BF-98D0-47CB-848F-563B0832793CQ34976999-505F5FA9-1C3B-4B83-B64D-5F9E2C2C7A3BQ35692292-621472B9-8326-4873-8D52-D52BE13B1449Q35825095-D6017A09-3B4E-4D2F-90B0-890473A658F7Q35880984-7584796C-C3D7-4014-A5A7-146B2BC4C8B9Q37157292-88613C1D-307C-4065-8725-194301B8CF5CQ38449459-773A0F25-2779-449C-AE9E-92FA57E7B953Q39252781-AE51A2C4-F463-489C-9A8E-232BEAEBBDBCQ40184652-4B71F5B0-8DC4-41DF-876F-D49AE7513B50Q40475053-DBC02578-91CF-4B46-8496-8C1C1C497CE7Q40611974-85B3DFD5-AB1A-41D2-B891-ED0559C65F6BQ40652821-E38613C0-9215-4080-8B38-E96D6E001D33Q40760466-AA3FE81C-A2CC-45D7-A9F9-190D44EE7B30Q40771756-D8E8295B-F589-4232-A4CE-7B7444238446Q40829337-62D4792A-67B6-4003-A03F-9D08AA6B8F2BQ41103868-9311D7F0-E433-4BD9-8DED-E3DE7D64048BQ41225029-96D62179-9091-4674-BC2C-D90CE6372920Q41392767-2AD404DA-10EA-4DE5-AB92-9351F2AC9FC8Q41523722-6F65C643-6292-4340-87B3-AD5FB1B44575Q43214065-1413DABF-B1F7-4C89-B6F0-F349CB39B4E1Q43422560-3DD0822C-E3A9-4C20-9500-D0607714EFF9Q43443910-34FF04A0-AD2E-4F31-802E-D68C9A723499Q43662757-85C8DA54-965E-41D8-9A7D-3EE218C8C0D1Q43725065-4851C08A-F07C-4E49-AE8D-C4153CD13058Q43737266-0CB91B90-1F87-43AC-A43E-6AC5725D0AFEQ43769344-68724917-E8B3-4192-BADB-AA8DFB4FE64CQ43946263-0B58C857-0FA3-457F-8BCB-2456D352B274Q43957625-E1AA8389-9EE1-4E6B-847F-D261588F0B3DQ44030877-4DD60A8B-6B52-4FDD-80F0-F08719B86F44Q44031760-2757C584-6F21-4E63-BE88-71DD3CD58E37Q44087280-ABD051CA-A396-4C81-A267-EF93B97A49ADQ44182225-06B7664E-C59E-4F11-872C-85CA6A563D66Q44479082-58120551-CE15-40BA-B3D3-4D83E972A1D2Q44766793-DE8AEB82-19D7-44DF-9F60-658B33A10A68Q44784114-40756636-A9CA-4C4F-9F9F-91DDA4BC18FAQ44949133-2D0A211D-B71A-4613-84C3-56C4ECD17ADAQ45415479-DD5ACF10-8AC1-4702-AC9C-33F78633CFFE
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jörg Schüpbach
@ast
Jörg Schüpbach
@en
Jörg Schüpbach
@es
Jörg Schüpbach
@nl
Jörg Schüpbach
@sl
type
label
Jörg Schüpbach
@ast
Jörg Schüpbach
@en
Jörg Schüpbach
@es
Jörg Schüpbach
@nl
Jörg Schüpbach
@sl
altLabel
Joerg Schuepbach
@en
Jorg Schupbach
@en
prefLabel
Jörg Schüpbach
@ast
Jörg Schüpbach
@en
Jörg Schüpbach
@es
Jörg Schüpbach
@nl
Jörg Schüpbach
@sl
P1006
P214
P244
P1006
P1053
G-4209-2016
P106
P21
P214
P244
P31
P3829
P496
0000-0002-8074-5891
P734
P735
P7859
lccn-n88185835